How much is the latest price of Apremilast in 2024?

Apremilast (Apremilast) is an oral medication used to treat a variety of inflammatory diseases, especially moderate to severe psoriasis and arthritic diseases such as psoriatic arthritis and psoriatic arthritis.

Apremilast is not currently available in China, so patients cannot purchase it domestically and need to purchase Apremilast through overseas channels. There are Apremilast original drugs and generic drugs abroad. The original drugs are mainly European versions of the original drugs, and the price is relatively high, about more than 10,000 yuan. The second cheaper one is the generic version of Apremilast, mainly the Indian version and the Lao version. The price is only about two to three hundred yuan, and the ingredients are basically the same as the original drug.

This drug is a phosphodioic acid esterase-4 (PDE4) inhibitor and works by inhibiting the activity of this enzyme. PDE4 is an enzyme involved in the inflammatory process and plays a role in regulating the production of inflammatory mediators in immune cells. Therefore, Apremilast reduces the production and release of inflammatory mediators by inhibiting the activity of PDE4, thereby alleviating the symptoms and signs of inflammatory diseases.

Psoriasis is a common chronic skin disease characterized by red, scaly lesions on the skin surface, often accompanied by itching and pain. Psoriatic arthritis is a complication of psoriasis that presents with arthritis symptoms such as joint pain, swelling, and limited mobility. These symptoms not only affect the patient's quality of life, but may also lead to joint dysfunction and disability.

As an oral medication, Apremilast is more convenient to use than some other treatment methods. It does not require injections or intravenous infusions, and patients can self-administer it at home. In addition, the side effects of Apremilast are relatively mild, generally including headache, nausea, diarrhea and other gastrointestinal reactions, and are well tolerated by most patients.

However, as an immunomodulatory drug, Apremilast may increase the risk of infection, so the patient's immune status needs to be closely monitored during use and avoid concurrent use with other immunosuppressants to reduce the risk of infection.